Single-Cell Omics Market Growth Outlook Through 2024-2033

Overview and Scope

Single-cell omics refers to the profile of single cells taken from heterogeneous populations of cells in various cellular stages, allowing for the study and dissection of both healthy development and disease processes at the single-cell level. Single-cell omics are used for the molecular analysis of cellular heterogeneity, cell type identification, illness research, and the creation of therapeutics.

Sizing and Forecast

The single-cell omics market size has grown rapidly in recent years. It will grow from $1.81 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to cellular heterogeneity discovery, emergence of single-cell analysis tools, biomedical research progress, immune system characterization, rise of precision medicine.

The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to clinical adoption and diagnostics, integration with multi-omics approaches, application in regenerative medicine, drug development and discovery, cellular therapies and immunotherapies. Major trends in the forecast period include in vivo single-cell studies, single-cell omics in infectious disease research, microfluidics and single-cell sorting, single-cell multi-omics integration, spatial single-cell profiling.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Segmentation & Regional Insights

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing
3) By Application: Oncology, Cell Biology, Neurology, Immunology
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

North America was the largest region in the single-cell omics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Major Driver Impacting Market Growth

The rising prevalence of cancer is expected to propel the growth of the single-cell omics market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Identifying biomarkers for cancer diagnosis, prognosis prediction and discovering novel therapeutic targets in predetermined clinical cohorts has made substantial use of single-cell omics data. For instance, in 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1.9 million new cancer cases are expected to be diagnosed in the US in 2021, an increase compared to more than 1.8 million new cancer cases diagnosed in 2020. Therefore, the rising prevalence of cancer is driving the growth of the single-cell omics market.

Key Industry Players

Major companies operating in the single-cell omics market report are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

The single-cell omics market report table of contents includes:

1. Executive Summary

2. Single-Cell Omics Market Characteristics

3. Single-Cell Omics Market Trends And Strategies

4. Single-Cell Omics Market – Macro Economic Scenario

5. Global Single-Cell Omics Market Size and Growth
…

32. Global Single-Cell Omics Market Competitive Benchmarking

33. Global Single-Cell Omics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Single-Cell Omics Market

35. Single-Cell Omics Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model